DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR THERAPY IN A CHILD WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Bu. Mueller et al., DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR THERAPY IN A CHILD WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of pediatrics, 126(5), 1995, pp. 749-752
We report a case of disseminated intravascular coagulopathy, apparentl
y caused by exposure to granulocyte colony-stimulating factor (G-CSF),
The medical records of patients treated for more than 30 consecutive
days with subcutaneously administered G-CSF were reviewed for the occu
rrence of thrombocytopenia or coagulation abnormalities, New-onset thr
ombocytopenia with a platelet count less than 100 X 10(9) cells/L (<10
0,000 cells/mm(3)) developed in 9 of 23 patients (39%) after a median
of II weeks of treatment with G-CSF at dosages between 1 and 10 mu g/k
g per day.